These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 4935524

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen.
    Zola H.
    Clin Exp Immunol; 1974 Mar; 16(3):469-79. PubMed ID: 4157121
    [Abstract] [Full Text] [Related]

  • 3. Immunologic stimuli in relation to leukemogenesis. 1. Potentiation of Rauscher viral leukemia by Freund's adjuvants.
    Siegel BV, Morton JI.
    J Natl Cancer Inst; 1972 Jun; 48(6):1681-5. PubMed ID: 4560295
    [No Abstract] [Full Text] [Related]

  • 4. Stimulation of Rauscher virus induced leukemogenesis in mice by complete Freund's adjuvant.
    Ter-Grigorov VS, Irlin IS, Moskovkina OIa, Bergol'ts VM.
    Vopr Onkol; 1971 Jun; 17(2):54-9. PubMed ID: 5567709
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of Freund's adjuvant on H-2 immunogenicity in mice.
    Cruse JM, Michelson ID.
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Jun; 130(5):433-43. PubMed ID: 4228968
    [No Abstract] [Full Text] [Related]

  • 8. [Humoral immunity in viral reticulosarcomatosis in mice].
    Bergol'ts VM, Moskovkina OIa, Sokolov PP, Sukhin GM, Kondrat'eva IA.
    Vopr Onkol; 1974 Jun; 20(11):35-9. PubMed ID: 4373907
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Cytotoxic and blocking antibodies in the sera and eluates from spleen cells of mice with Rauscher leukemia following a different course].
    Ter-Grigorov VS, Dzagurov SG, Shevelev BI.
    Biull Eksp Biol Med; 1975 Feb; 79(2):76-80. PubMed ID: 48386
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adjuvant-induced enhancement of the immune response to the Moloney tumor antigen.
    Wells SA, Wigzell H.
    Surg Forum; 1968 Feb; 19():87-9. PubMed ID: 5718429
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Role of 7S- and 19S-antibodies in the mechanism of stimulation and inhibition of Rauscher virus leukemia in mice].
    Ter-Grigorov VS, Shevelev BI, Moskovkina OIa, Bergol'ts VM.
    Biull Eksp Biol Med; 1971 Jan; 71(1):61-4. PubMed ID: 5552664
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Early suppression with late acceleration of syngeneic tumor growth by Freund's adjuvant.
    Cruse JM.
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Feb; 132(2):196-201. PubMed ID: 4230697
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.